Annual EBIT:
-$568.20M+$639.54M(+52.95%)Summary
- As of today, ONC annual earnings before interest & taxes is -$568.20 million, with the most recent change of +$639.54 million (+52.95%) on December 31, 2024.
- During the last 3 years, ONC annual EBIT has risen by +$870.54 million (+60.51%).
- ONC annual EBIT is now -11889.85% below its all-time high of -$4.74 million, reached on December 1, 2013.
Performance
ONC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$163.33M+$75.14M(+85.19%)Summary
- As of today, ONC quarterly earnings before interest & taxes is $163.33 million, with the most recent change of +$75.14 million (+85.19%) on September 30, 2025.
- Over the past year, ONC quarterly EBIT has increased by +$283.59 million (+235.81%).
- ONC quarterly EBIT is now at all-time high.
Performance
ONC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$183.49M+$283.59M(+283.28%)Summary
- As of today, ONC TTM earnings before interest & taxes is $183.49 million, with the most recent change of +$283.59 million (+283.28%) on September 30, 2025.
- Over the past year, ONC TTM EBIT has increased by +$1.06 billion (+121.03%).
- ONC TTM EBIT is now at all-time high.
Performance
ONC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ONC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +53.0% | +235.8% | +121.0% |
| 3Y3 Years | +60.5% | +137.3% | +109.7% |
| 5Y5 Years | +40.8% | +137.1% | +111.8% |
ONC EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +68.3% | at high | +134.8% | at high | +109.7% |
| 5Y | 5-Year | at high | +68.3% | at high | +128.5% | at high | +109.4% |
| All-Time | All-Time | >-9999.0% | +68.3% | at high | +128.5% | at high | +109.4% |
ONC EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $163.33M(+85.2%) | $183.49M(+283.3%) |
| Jun 2025 | - | $88.19M(+694.4%) | -$100.11M(+66.1%) |
| Mar 2025 | - | $11.10M(+114.0%) | -$295.46M(+48.0%) |
| Dec 2024 | -$568.20M(+53.0%) | -$79.14M(+34.2%) | -$567.91M(+34.9%) |
| Sep 2024 | - | -$120.27M(-12.2%) | -$872.57M(+1.5%) |
| Jun 2024 | - | -$107.16M(+59.0%) | -$886.27M(+19.3%) |
| Mar 2024 | - | -$261.35M(+31.9%) | -$1.10B(+9.1%) |
| Dec 2023 | -$1.21B(+32.5%) | -$383.80M(-186.5%) | -$1.21B(+6.6%) |
| Sep 2023 | - | -$133.97M(+58.0%) | -$1.29B(+19.1%) |
| Jun 2023 | - | -$318.71M(+14.2%) | -$1.60B(+7.0%) |
| Mar 2023 | - | -$371.26M(+20.8%) | -$1.72B(+4.0%) |
| Dec 2022 | -$1.79B(-24.4%) | - | - |
| Dec 2022 | - | -$468.62M(-6.9%) | -$1.79B(+5.5%) |
| Sep 2022 | - | -$438.36M(+0.2%) | -$1.89B(+1.2%) |
| Jun 2022 | - | -$439.40M(+0.9%) | -$1.92B(+1.8%) |
| Mar 2022 | - | -$443.29M(+22.6%) | -$1.95B(-35.7%) |
| Dec 2021 | -$1.44B(+13.2%) | -$572.83M(-23.9%) | -$1.44B(-6.5%) |
| Sep 2021 | - | -$462.32M(+2.6%) | -$1.35B(-1.7%) |
| Jun 2021 | - | -$474.84M(-776.7%) | -$1.33B(-9.6%) |
| Mar 2021 | - | $70.17M(+114.5%) | -$1.21B(+26.8%) |
| Dec 2020 | -$1.66B | -$484.91M(-10.2%) | -$1.66B(-6.2%) |
| Sep 2020 | - | -$440.14M(-22.6%) | -$1.56B(-8.9%) |
| Jun 2020 | - | -$358.88M(+4.0%) | -$1.43B(-23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$373.76M(+3.7%) | -$1.16B(-20.8%) |
| Dec 2019 | -$959.89M(-36.0%) | -$388.04M(-24.3%) | -$959.89M(-12.6%) |
| Sep 2019 | - | -$312.27M(-263.8%) | -$852.66M(-23.3%) |
| Jun 2019 | - | -$85.83M(+50.6%) | -$691.50M(+10.0%) |
| Mar 2019 | - | -$173.75M(+38.1%) | -$768.72M(-8.9%) |
| Dec 2018 | -$705.77M(-616.8%) | -$280.81M(-85.8%) | -$705.77M(-33.5%) |
| Sep 2018 | - | -$151.10M(+7.3%) | -$528.76M(-101.2%) |
| Jun 2018 | - | -$163.05M(-47.1%) | -$262.75M(-66.6%) |
| Mar 2018 | - | -$110.81M(-6.8%) | -$157.72M(-60.2%) |
| Dec 2017 | -$98.46M(+15.9%) | -$103.80M(-190.3%) | -$98.46M(-208.4%) |
| Sep 2017 | - | $114.91M(+298.0%) | -$31.93M(+82.4%) |
| Jun 2017 | - | -$58.02M(-12.6%) | -$181.66M(-22.5%) |
| Mar 2017 | - | -$51.54M(-38.3%) | -$148.27M(-26.7%) |
| Dec 2016 | -$117.06M(-106.3%) | -$37.27M(-7.0%) | -$117.06M(-10.3%) |
| Sep 2016 | - | -$34.83M(-41.4%) | -$106.17M(-4.4%) |
| Jun 2016 | - | -$24.63M(-21.1%) | -$101.71M(-23.4%) |
| Mar 2016 | - | -$20.33M(+22.9%) | -$82.45M(-14.4%) |
| Dec 2015 | -$56.74M(-260.1%) | -$26.38M(+13.1%) | -$72.06M(-44.5%) |
| Sep 2015 | - | -$30.37M(-465.7%) | -$49.87M(-79.4%) |
| Jun 2015 | - | -$5.37M(+46.0%) | -$27.80M(-23.9%) |
| Mar 2015 | - | -$9.95M(-137.5%) | -$22.43M(-79.6%) |
| Dec 2014 | -$15.76M(-232.5%) | -$4.19M(+49.5%) | -$12.49M(-50.5%) |
| Sep 2014 | - | -$8.30M | -$8.30M |
| Dec 2013 | -$4.74M | - | - |
FAQ
- What is BeOne Medicines Ltd. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. annual EBIT year-on-year change?
- What is BeOne Medicines Ltd. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. quarterly EBIT year-on-year change?
- What is BeOne Medicines Ltd. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. TTM EBIT year-on-year change?
What is BeOne Medicines Ltd. annual earnings before interest & taxes?
The current annual EBIT of ONC is -$568.20M
What is the all-time high annual EBIT for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high annual earnings before interest & taxes is -$4.74M
What is BeOne Medicines Ltd. annual EBIT year-on-year change?
Over the past year, ONC annual earnings before interest & taxes has changed by +$639.54M (+52.95%)
What is BeOne Medicines Ltd. quarterly earnings before interest & taxes?
The current quarterly EBIT of ONC is $163.33M
What is the all-time high quarterly EBIT for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high quarterly earnings before interest & taxes is $163.33M
What is BeOne Medicines Ltd. quarterly EBIT year-on-year change?
Over the past year, ONC quarterly earnings before interest & taxes has changed by +$283.59M (+235.81%)
What is BeOne Medicines Ltd. TTM earnings before interest & taxes?
The current TTM EBIT of ONC is $183.49M
What is the all-time high TTM EBIT for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high TTM earnings before interest & taxes is $183.49M
What is BeOne Medicines Ltd. TTM EBIT year-on-year change?
Over the past year, ONC TTM earnings before interest & taxes has changed by +$1.06B (+121.03%)